在剖腹产中带血的富血小板血伤口管理
Amornrat Thanachaiviwat1, Sutham Suthaporn1, Patana Teng-Umnuay2
1Department of Obstetrics and Gynaecology, Division of Obstetrics and Gynaecology, Police General Hospital, Bangkok, Thailand.
Obstetrics and gynecology international
|December 20, 2024
概括
带血中富有血小板血 (CB-PRP) 的应用改善了剖腹产患者的伤口愈合,REEDA和温哥华痕量表得分较低证明了这一点. 然而,CB-PRP并没有显著减少术后疼痛.
科学领域:
- 产科和妇科 产科和妇科
- 再生医学是一种再生医学.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 众所周知,富含血小板血 (PRP) 可以增强伤口愈合和减少疼痛.
- 带血富血小板血 (CB-PRP) 是一种潜在的PRP替代来源,可以很容易地从带中获得.
- 建议将其应用于剖腹产伤口,提供类似的治疗益处.
研究的目的:
- 研究CB-PRP在改善伤口愈合和减少剖腹产妇女疼痛方面的疗效.
- 评估CB-PRP对术后伤口愈合的影响,使用标准化尺度.
- 评估CB-PRP在早期术后期缓解疼痛的影响.
主要方法:
- 进行了一项随机对照试验,52名参与者接受了剖腹产.
- 参与者被分为接受CB-PRP的干预组和对照组.
- 在剖腹产后立即将CB-PRP应用于外科创伤部位.
- 使用REEDA尺度 (第1天和第3天) 和温哥华痕尺度 (VSS) (8周) 评估伤口愈合.
- 在术后的第1天和第3天,使用视觉模拟量表 (VAS) 评估疼痛.
主要成果:
- 在手术后的第一天,CB-PRP组的REEDA评分显着较低 (p=0.009).
- 在手术后8周的CB-PRP组中观察到温哥华痕量表 (VSS) 得分明显较低 (p < 0.001).
- 在CB-PRP和对照组之间,视觉模拟量表 (VAS) 疼痛评分没有显著差异.
结论:
- CB-PRP的应用显示出在剖腹产后促进伤口愈合的潜力.
- 该研究没有发现证据表明CB-PRP在这种情况下可以减少术后疼痛.
- 需要进一步的研究来证实伤口愈合的好处,并探索CB-PRP的潜在缓解疼痛的机制.
相关概念视频
Formation of the Platelet Plug
4.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.2K
Introduction to Hemostasis
5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K


